Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: Combinations with 5-fluorouracil and interferon-alpha

被引:13
作者
Louvet, C
Djelloul, S
ForgueLafitte, ME
Mester, J
Zimber, A
Gespach, C
机构
[1] HOP ST ANTOINE, SERV MED INTERNE, F-75012 PARIS, FRANCE
[2] HEBREW UNIV JERUSALEM, FAC AGR, IL-91905 JERUSALEM, ISRAEL
关键词
retinoid; Ro; 40-8757; human colonic; gastric; pancreatic cancer cell;
D O I
10.1038/bjc.1996.371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The arotinoid Ro 40-8757 was previously shown to inhibit the growth of a variety of human cancer cell lines derived from breast, lung and uterus. In view of the high incidence of human digestive cancers, and the slow progress in the development of new therapy, we examined in this paper several combinations between the new arotinoid Ro 40-8757, 5-fluorouracil (5FU) and interferon alpha-2a on the growth of nine human cancer cell lines derived from the gastrointestinal and pancreatic system. Half-maximal inhibition of cell proliferation by Ro 40-8757 was observed at concentrations ranging between 0.18 and 0.57 mu M, and increased up to 4.7 mu M in retinoid-resistant CAPAN 620 pancreatic cells. All-trans-retinoic acid was 70 times less potent. The sensitivity of HT29-5FU-resistant colonic cells was similar to that observed in the parental cells, suggesting an action independent of pyrimidine metabolism. Ro 40-8757 did not induce any differentiation on HT29 cells, as suggested by ultrastructural analysis. The arotinoid did not interact with receptor signal transduction pathways under the control of serum components, such as growth factors as half-maximal inhibition of growth was similar in HT29-S-B6 cells cultured in the absence or presence of serum. Cell cycle analysis showed that Ro 40-8757 was not acting al a phase-specific transition in HT29 cells and, accordingly, did not induce overexpression of the protein kinase C (PKC)alpha isoform, or conversion of hyperphosphorylated p105 Rb into hypophosphorylated forms. However, the arotinoid induced significant accumulation of the dephosphorylated, active form of the tumour-suppressor protein. Combinations of Ro 40-8757 with 5FU and interferon alpha 2a resulted in an additive but not synergistic antiproliferative action in HT29 cells. Our data support the interest in Ro 40-8757 as a potent anti-cancer drug, especially in combination therapy with 5FU and interferon, in gastrointestinal and pancreatic cancers, where new active therapeutic modalities are urgently needed.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 46 条
[1]  
[Anonymous], 1997, NIIGATA IGAKKAI ZASS
[2]  
BLOBE GC, 1993, J BIOL CHEM, V268, P658
[3]  
BOLLAG W, 1994, LEUKEMIA, V8, P1453
[4]   THE RETINOBLASTOMA PROTEIN IS PHOSPHORYLATED DURING SPECIFIC PHASES OF THE CELL-CYCLE [J].
BUCHKOVICH, K ;
DUFFY, LA ;
HARLOW, E .
CELL, 1989, 58 (06) :1097-1105
[5]   INDEPENDENT BINDING OF THE RETINOBLASTOMA PROTEIN AND P107 TO THE TRANSCRIPTION FACTOR E2F [J].
CAO, L ;
FAHA, B ;
DEMBSKI, M ;
TSAI, LH ;
HARLOW, E ;
DYSON, N .
NATURE, 1992, 355 (6356) :176-179
[6]  
CASTAIGNE S, 1990, BLOOD, V76, P1704
[7]   NEOPLASTIC PROGRESSION OF HUMAN AND RAT INTESTINAL-CELL LINES AFTER TRANSFER OF THE RAS AND POLYOMA MIDDLE T-ONCOGENES [J].
CHASTRE, E ;
EMPEREUR, S ;
DIGIOIA, Y ;
ELMAHDANI, N ;
MAREEL, M ;
VLEMINCKX, K ;
VANROY, F ;
BEX, V ;
EMAMI, S ;
SPANDIDOS, DA ;
GESPACH, C .
GASTROENTEROLOGY, 1993, 105 (06) :1776-1789
[8]   THE E2F TRANSCRIPTION FACTOR IS A CELLULAR TARGET FOR THE RB PROTEIN [J].
CHELLAPPAN, SP ;
HIEBERT, S ;
MUDRYJ, M ;
HOROWITZ, JM ;
NEVINS, JR .
CELL, 1991, 65 (06) :1053-1061
[9]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[10]  
CRAVEN RJ, 1995, CANCER RES, V55, P3969